Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/1998
01/28/1998EP0820290A1 Use of vitamin d 2 or vitamin d 4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
01/28/1998EP0820288A1 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence
01/28/1998EP0641791B1 Novel benzothiophene derivative
01/28/1998EP0639970B1 Contraception method using competitive progesterone antagonists and novel compounds useful therein
01/28/1998CN1171743A Novel tumor suppressor gene HIC-1
01/28/1998CN1171267A Clinical application of gamma-interferon in emergency contraception
01/28/1998CN1171266A Fuyanyu (exterior-use capsule)
01/28/1998CN1171261A Medicine for dispelling colds and warming kidney
01/28/1998CN1037179C 1, 4 -benzoxazino derivatives
01/28/1998CN1037176C Benzenealkanoic acids for cardiovascular diseases
01/27/1998US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines
01/27/1998US5712294 Antiinflammatory agents
01/27/1998US5712287 Method of treating urinary bladder dysfunctions
01/27/1998US5712271 Method of treating urinary bladder dysfunctions
01/27/1998US5712122 Carboxy terminal peptide-extended proteins
01/24/1998CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists
01/22/1998WO1998002452A2 Compounds and methods for modulating cell adhesion
01/22/1998WO1998002167A1 Transdermal application of naturally occurring steriod hormones
01/22/1998WO1998002154A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
01/22/1998WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
01/22/1998CA2259966A1 Compounds and methods for modulating cell adhesion
01/21/1998EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
01/21/1998EP0819009A1 Ovulation triggering drugs
01/21/1998EP0819001A1 Use of substituted piperidine or pyrrolidine compounds for treating sigma-receptor modulated disorders
01/21/1998EP0625977B1 Piperazine derivatives as 5-ht1a antagonists
01/21/1998CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases
01/21/1998CN1171113A Mutants of Rb and p53 genes and uses thereof
01/21/1998CN1171051A Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception
01/21/1998CN1170719A Estrogenic agents
01/21/1998CN1170582A Chinese drug for curing and preventing mastosis and its preparing method
01/20/1998US5710275 7β-substituted-4-aza-5α-androstan-3-ones as 5α-reductase inhibitors
01/20/1998US5710169 Therapeutic heterocycles
01/20/1998US5710151 Method of treating urinary bladder dysfunctions
01/20/1998US5710149 Piperazine derivatives as 5-ht antagonists
01/20/1998US5710140 Phenyl heterocycles as COX-2 inhibitors
01/20/1998US5710139 Heterocyclic compounds
01/20/1998US5710022 Nuclear mitotic phosphoprotein
01/20/1998US5709881 Tablet capsule or granule comprising desogestrel
01/20/1998US5709860 Induction of cytotoxic T-lymphocyte responses
01/20/1998CA2059000C Fused-ring aryl substituted imidazoles
01/15/1998WO1998001115A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
01/15/1998CA2258525A1 Combined pharmaceutical estrogen-androgen-progestin oral contraceptive
01/14/1998EP0818453A1 Benzothiophene compounds and methods of use
01/14/1998EP0817800A1 Human g-protein coupled receptors
01/14/1998EP0817645A1 Method for treatment of benign prostatic hypertrophy
01/14/1998EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
01/14/1998EP0684825A4 Method of preventing or inhibiting fertilization.
01/14/1998EP0662950B1 Benzenealkanoic acids for cardiovascular diseases
01/14/1998CN1170354A Unitary vaginal dosage form useful as local contraciptive and/or for combatting sexually transmitted deseases and/or HIV
01/13/1998US5708034 Substituted sulfonimidamides, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
01/13/1998US5708023 Nonirritating gel for skin
01/13/1998US5708020 Arylalkyl(thio)amides
01/13/1998US5708016 Pseudopeptides derived from neurokinins
01/13/1998US5708010 Methods of inhibiting myeloperoxidase activity
01/13/1998US5708009 Methods of inhibiting myeloperoxidase activity
01/13/1998US5707999 Urogenital disorders
01/13/1998US5707980 Administering 1a,25-dihydroxyvitamin d4 to patient
01/13/1998US5707826 Transpeptidation, replacing terminal portion of peptide sequence with another sequence, forming amide at c-terminal position in one step
01/13/1998US5707635 Containing a crosslinked polyacrylamide-type polymer and an active compound, optionally a humectant and an emollient
01/10/1998CA2206997A1 Benzothiophene compounds and methods of use
01/08/1998WO1998000440A1 Immunocontraceptive compositions containing sperm antigens, and methods of use
01/08/1998WO1998000164A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
01/08/1998WO1997041824A3 Antiangiogenic peptides derived from plasminogen
01/08/1998CA2259147A1 Immunocontraceptive compositions containing sperm antigens, and methods of use
01/08/1998CA2258717A1 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
01/07/1998EP0816360A1 Benzothiophene compounds, intermediates, processes, and methods of use
01/07/1998EP0816357A1 Substituted indazole derivatives
01/07/1998EP0815255A1 Hormone and growth factor phosphoglycan mimetics from mycobacterium vaccae
01/07/1998EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus
01/07/1998EP0815126A1 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical composition
01/07/1998EP0814821A1 Immunomodulating compositions from bile for the treatment of immune system disorders
01/07/1998EP0814803A2 Use of anti-oestrogens as male contraceptives
01/07/1998EP0814800A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
01/07/1998EP0814792A1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase
01/07/1998EP0814785A1 Use of nitric oxide donors or nitric oxide inhibitors for regulating cervical dilatation and extensibility
01/07/1998EP0814775A1 Method and kit for preventing erectile dysfunction
01/07/1998CN1169312A Junbisha privates-cleaning effervescence preparation and preparation technology thereof
01/07/1998CN1036918C Novel benzopyran derivatives and activating agent containing same
01/06/1998US5705658 Azido containing tetrahydro furan compounds
01/06/1998US5705507 Aplha-substituted-3-benzyl-benzofurans
01/06/1998US5705494 Anti-estrogenic activity of IIβ-substituted-19-NOR Steroids
01/06/1998CA1339623C Lhrh antagonists
01/02/1998CA2206752A1 Benzothiophene compounds, intermediates, processes, and methods of use
12/1997
12/31/1997WO1997049707A1 Tricyclic benzazepine vasopressin antagonists
12/31/1997WO1997049407A1 Progestogen-anti-progestogen regimens
12/31/1997CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia
12/31/1997CN1036836C Method for preparing medicine for transcortical application contg. steroidhormonen
12/31/1997CA2258885A1 Tricyclic benzazepine vasopressin antagonists
12/31/1997CA2255863A1 Progestogen-anti-progestogen regimens
12/30/1997US5703113 Benzopyran derivatives
12/30/1997US5703112 Method of preventing emesis using tetrahydrobenz CD!indole-6-carbonxamides
12/30/1997US5703106 Treating various cardiovascular, urogenital, brain disorders
12/30/1997US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives
12/30/1997US5703066 Treating gynecological disorders
12/29/1997EP0814158A2 Human C3a receptor variant; uses in diagnostics and therapeutics
12/29/1997EP0813875A2 Inhibition of abnormal accumulation of extracellular matrices
12/29/1997EP0813871A1 Berberine derivates for inhibiting production of HSP47
12/29/1997EP0813595A1 Stimulation of meiosis
12/29/1997EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity
12/29/1997EP0813417A1 Use of hyaluronic acid for the treatment of interstitial cystitis